1Akbari CM,Macsata R,Smith BM,et al.Overview of the Diabetic foot[J].Semi Vasc Surg,2003,16 (1):3-11.
2Creager MA,Luscher TH,Cosentino F,et al.Diabetes and Vascular Disease Pathophysiology,Clinical Consequences,and Medical Therapy:Part Ⅱ[J].Circulation,2003,108 (13):1655-1661.
3Dormandy JA,Rutherford RB.Management of peripheral arterial disease.TASC Working Group[J].J Vasc Surg,2000,31 (1 Pt 2):1 -296.
4Klinkert P,schepers A,Burger DH,et al.Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting:five-year results of a randomized controlled trial[J].J Vasc Surg,2003,37(1):149-155.
5Johnson WC,Lee KK.A comparative evaluation of polytetrafluoroethylene,umbilical vein,and saphenous vien bypass grafts for femoral-popliteal above-knee revascularization:a prospective randomized Department of Veteran Affairs cooperative study[J].J Vasc Surg,2000,32 (2):268-277.
6Ballotta E,Renon L,Toffano M,et al.Prospective randomized study on bilateral above-knee femoropopliteal revascularization:Polytetrafluoroethylene graft versus reversed saphenous vein[J].J Vasc Surg,2003,38(5):1051-1055.
7Sala F,Hassen-Khodja R,Lecis A,et al.Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts[J].Ann Vasc Surg,2003,17(4):401 -407.
8Mamode N,Scott RN.Graft type for femoro-popliteal bypass surgery[J].Cochrane Database Syst Rev,2000,(2):CD001487.
9Devine C,McCollum C,North West Femoro-Popliteal Trial Participants.Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass:five-year results of a prospective randomized multicenter clinical trial[J].J Vasc Surg,2004,40(5):924-931.
10Surowiec SM,Davies MG,Eberly SW,et al.Percutaneous angioplasty and stenting of the superficial femoral artery[J].J Vase Surg,2005,41 (2):269-278.
